Project Team Lead at Manifold Bio

Boston, Massachusetts, United States

Manifold Bio Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

  • A PhD degree in life sciences or a scientific discipline related to drug development; MD, PharmD or MS with strong scientific and drug development background also considered
  • At least 7 years of biotech/pharmaceutical industry experience in drug development, spanning from discovery through initiation of first-in-human clinical studies
  • Experience in discovery and development of biologic and/or oligonucleotide therapies, with a focus on neuroscience, motor, or cardiometabolic therapeutic areas preferred
  • Excellent knowledge of drug development processes and deliverables at each stage of the pipeline
  • Successful track record of leading projects/program teams in a cross-functional team environment from early discovery through IND-enabling activities and ideally through early clinical development
  • Experience successfully leading projects with participation by external collaborators
  • Experience in overs (incomplete in description)

Responsibilities

  • Provides strategic and scientific leadership for cross-functional project teams focused on the development of tissue-targeted therapeutic molecules as they transition from early discovery (lead identification) into early clinical development
  • Develops clear work plan that maps out timing and resourcing required to execute on critical path activities to progress novel lead tissue-targeted therapies from lead ID through early clinical testing, including candidate nomination, nonclinical PK and safety evaluation, CMC activities, regulatory submissions, and early clinical testing
  • Maintains team focus on efficient execution IND-enabling workplans. Works with project managers to track execution of critical path activities relative to target timelines and budget
  • Updates strategy based on emerging scientific data, changes in competitive landscape, and company strategic priorities; supports timely and clear project team decision-making that aligns with that strategy
  • Facilitates identification and resolution of issues/gaps; risks and risk-mitigation strategies. Prioritizes timely, resource-efficient solutions that are aligned with company priorities
  • Ensures cross-functional project team decisions are made in a timely manner and are aligned with company strategic priorities and latest scientific data
  • Advocates for the program with internal and external stakeholders; supports two-way communication between senior leadership and project team members. Ensures the opinions and perspectives of internal and external partners and stakeholders are heard and understood
  • Fosters a team culture of rigor, grit, accountability, and continuous improvement

Skills

Drug Discovery
Drug Development
Project Leadership
Cross-Functional Teams
Lead Identification
Candidate Nomination
Nonclinical PK
Safety Evaluation
CMC
Regulatory Submissions
Clinical Development
Tissue-Targeted Therapeutics

Manifold Bio

Designs precision biologics using in vivo methods

About Manifold Bio

Manifold Bio specializes in creating precision biologics for the pharmaceutical industry, focusing on drug design and development. Their main product is an in vivo drug design platform, which allows for testing drugs within living organisms rather than in laboratory settings. This platform utilizes mCodes™ technology, a unique protein barcoding system that enables the simultaneous study of multiple proteins in one experiment, making it particularly effective for complex biologics. Unlike other companies, Manifold Bio's approach to drug design is distinct because it integrates in vivo testing with advanced protein multiplexing capabilities. The company's goal is to expand their platform and collaborate with other pharmaceutical companies to develop new therapeutics.

Boston, MassachusettsHeadquarters
2020Year Founded
$58.8MTotal Funding
SERIES_ACompany Stage
Biotechnology, HealthcareIndustries
11-50Employees

Risks

Increased competition from companies like Insamo and Infinimmune.
Rapid AI and ML advancements may outpace Manifold Bio's current technology.
Regulatory challenges in in vivo testing could delay product development timelines.

Differentiation

Manifold Bio uses proprietary mCodes™ technology for protein multiplexing in drug design.
Their in vivo drug design platform is the first of its kind globally.
The company specializes in precision biologics, focusing on complex biologics development.

Upsides

Raised $40M in Series A funding, indicating strong market interest.
Their platform could revolutionize in vivo testing by testing multiple molecules simultaneously.
Strategic partnerships with multiple investors enhance growth and development opportunities.

Land your dream remote job 3x faster with AI